Cihangir Duy

2.5k total citations
30 papers, 955 citations indexed

About

Cihangir Duy is a scholar working on Hematology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Cihangir Duy has authored 30 papers receiving a total of 955 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 14 papers in Molecular Biology and 14 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Cihangir Duy's work include Acute Lymphoblastic Leukemia research (14 papers), Chronic Myeloid Leukemia Treatments (11 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Cihangir Duy is often cited by papers focused on Acute Lymphoblastic Leukemia research (14 papers), Chronic Myeloid Leukemia Treatments (11 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Cihangir Duy collaborates with scholars based in United States, Germany and Italy. Cihangir Duy's co-authors include Jörg Fitter, Ari Melnick, Markus Müschen, Hassan Jumaa, Gregor von Levetzow, Wolf‐Karsten Hofmann, Meng Li, Niklas Feldhahn, Nadine Henke and Lars Klemm and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and Blood.

In The Last Decade

Cihangir Duy

28 papers receiving 942 citations

Peers

Cihangir Duy

HEMAT

IMMUN

PHEOH

ONCOL

Manujendra N. Saha Canada

Lisa M. Chelstrom United States

Pradeep S. Chauhan United States

Vicente Fresquet Spain

Carsten Berges Germany

Maria L. Amaya United States

Juraj Bodo United States

Andreas Baumann Germany

Michal Stark Israel

Louise F. Momparler Canada

Manujendra N. Saha Canada

Cihangir Duy

610 ×1.2

232 ×1.0

HEMAT

145 ×0.7

IMMUN

57 ×0.4

PHEOH

333 ×2.4

ONCOL

Citations per year, relative to Cihangir Duy Cihangir Duy (= 1×) peers Manujendra N. Saha

Countries citing papers authored by Cihangir Duy

Since Specialization

Citations

This map shows the geographic impact of Cihangir Duy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cihangir Duy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cihangir Duy more than expected).

Fields of papers citing papers by Cihangir Duy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cihangir Duy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cihangir Duy. The network helps show where Cihangir Duy may publish in the future.

Co-authorship network of co-authors of Cihangir Duy

This figure shows the co-authorship network connecting the top 25 collaborators of Cihangir Duy. A scholar is included among the top collaborators of Cihangir Duy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cihangir Duy. Cihangir Duy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Myllykoski, Matti, John Z. Cao, Bill H. Diplas, et al.. (2023). (R) -2-Hydroxyglutarate Inhibits KDM5 Histone Lysine Demethylases to Drive Transformation in IDH -Mutant Cancers. Cancer Discovery. 13(6). 1478–1497. 22 indexed citations

Li, Meng, Matthew Teater, Jun Young Hong, et al.. (2021). Translational Activation of ATF4 through Mitochondrial Anaplerotic Metabolic Pathways Is Required for DLBCL Growth and Survival. Blood Cancer Discovery. 3(1). 50–65. 18 indexed citations

Duy, Cihangir, Meng Li, Matt Teater, et al.. (2021). Chemotherapy Induces Senescence-Like Resilient Cells Capable of Initiating AML Recurrence. Cancer Discovery. 11(6). 1542–1561. 153 indexed citations

Duy, Cihangir, Wendy Béguelin, & Ari Melnick. (2020). Epigenetic Mechanisms in Leukemias and Lymphomas. Cold Spring Harbor Perspectives in Medicine. 10(12). a034959–a034959. 12 indexed citations

Li, Meng, Matt Teater, Cem Meydan, et al.. (2020). Abstract 651: Chemotherapy induces a transient senescence-like state capable of initiating AML recurrence. Cancer Research. 80(16_Supplement). 651–651. 1 indexed citations

Li, Meng, Ying‐Ling Chiang, Costas A. Lyssiotis, et al.. (2019). Non-oncogene Addiction to SIRT3 Plays a Critical Role in Lymphomagenesis. Cancer Cell. 35(6). 916–931.e9. 87 indexed citations

Hatzi, Katerina, Huimin Geng, Ashley S. Doane, et al.. (2018). Histone demethylase LSD1 is required for germinal center formation and BCL6-driven lymphomagenesis. Nature Immunology. 20(1). 86–96. 60 indexed citations

Swaminathan, Srividya, Cihangir Duy, & Markus Müschen. (2013). BACH2–BCL6 balance regulates selection at the pre-B cell receptor checkpoint. Trends in Immunology. 35(3). 131–137. 27 indexed citations

Nahar, Rahul, Parham Ramezani-Rad, Maximilian Mossner, et al.. (2011). Pre-B Cell Receptor-Mediated Activation of BCL6 Induces Pre-B Cell Quiescence Through Transcriptional Repression of MYC. Blood. 118(21). 1406–1406. 1 indexed citations

10.

Nahar, Rahul, Parham Ramezani-Rad, Maximilian Mossner, et al.. (2011). Pre-B cell receptor–mediated activation of BCL6 induces pre-B cell quiescence through transcriptional repression of MYC. Blood. 118(15). 4174–4178. 48 indexed citations

11.

Duy, Cihangir, Daniel Nowak, Lars Klemm, et al.. (2010). Mechanisms of Pre-B Cell Receptor-Inactivation In Acute Lymphoblastic Leukemia. Blood. 116(21). 147–147. 2 indexed citations

12.

Klemm, Lars, Cihangir Duy, Ilaria Iacobucci, et al.. (2009). The B Cell Mutator AID Promotes B Lymphoid Blast Crisis and Drug Resistance in Chronic Myeloid Leukemia. Cancer Cell. 16(3). 232–245. 120 indexed citations

13.

Park, Eugene, Gregor von Levetzow, Cihangir Duy, et al.. (2009). Role of Survivin in Drug Resistant B-Cell Acute Lymphoblastic Leukemia.. Blood. 114(22). 10–10. 8 indexed citations

14.

Duy, Cihangir, Mieke Sprangers, Lars Klemm, et al.. (2009). Inactivation of Pre-B Cell Receptor-Mediated Tumor Suppression by Aberrant Splicing in Ph+ Acute Lymphoblastic Leukemia.. Blood. 114(22). 579–579. 1 indexed citations

15.

Duy, Cihangir, Jinmei Yu, Srividya Swaminathan, et al.. (2009). BCL6 Is Critical for the Development of a Diverse Primary B Cell Repertoire.. Blood. 114(22). 91–91. 1 indexed citations

16.

Trageser, Daniel, Ilaria Iacobucci, Rahul Nahar, et al.. (2009). Pre–B cell receptor–mediated cell cycle arrest in Philadelphia chromosome–positive acute lymphoblastic leukemia requires IKAROS function. The Journal of Experimental Medicine. 206(8). 1739–1753. 91 indexed citations

17.

Feldhahn, Niklas, Nadine Henke, Cihangir Duy, et al.. (2007). Activation-induced cytidine deaminase acts as a mutator in BCR-ABL1–transformed acute lymphoblastic leukemia cells. The Journal of Experimental Medicine. 204(5). 1157–1166. 70 indexed citations

18.

Duy, Cihangir, Ignacio Moreno de Alborán, Hassan Jumaa, & Markus Müschen. (2007). The Balance between Myc and Bcl6 Determines Self-Renewal or Differentiation of Pre-B Cells.. Blood. 110(11). 797–797. 1 indexed citations

19.

Duy, Cihangir & Jörg Fitter. (2006). How Aggregation and Conformational Scrambling of Unfolded States Govern Fluorescence Emission Spectra. Biophysical Journal. 90(10). 3704–3711. 143 indexed citations

20.

Duy, Cihangir & Jörg Fitter. (2005). Thermostability of Irreversible Unfolding α-Amylases Analyzed by Unfolding Kinetics. Journal of Biological Chemistry. 280(45). 37360–37365. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact